Daxor Corporation (DXR) P/E Ratio History
Historical price-to-earnings valuation from 1989 to 2025
Loading P/E history...
DXR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Daxor Corporation (DXR) trades at a price-to-earnings ratio of 87.8x, with a stock price of $9.66 and trailing twelve-month earnings per share of $0.70.
The current P/E is 249% above its 5-year average of 25.2x. Over the past five years, DXR's P/E has ranged from a low of 1.3x to a high of 135.0x, placing the current valuation at the 90th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, DXR trades at a 293% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, DXR commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DXR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DXR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $17B | 30.5 | - | -25% | |
| $56B | 26.3 | 1.59 | -1% | |
| $161B | 57.6 | 2.65 | +23% | |
| $151B | 11.4Lowest | 0.38Best | +134%Best | |
| $100B | 21.6 | - | +31% | |
| $113B | 35.0 | 2.36 | +8% | |
| $16B | 23.5 | - | -20% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
DXR Historical P/E Data (1989–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $9.79 | $0.75 | 13.1x | -87% |
| FY2024 Q4 | $7.69 | $0.36 | 21.4x | -78% | |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $9.32 | $0.73 | 12.8x | -87% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $9.60 | $0.85 | 11.3x | -88% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $9.60 | $0.91 | 10.5x | -89% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $9.16 | $1.18 | 7.8x | -92% |
| FY2022 Q2 | $13.20 | $0.60 | 22.0x | -77% | |
| FY2017 Q4 | Sun Dec 31 2017 00:00:00 GM | $4.57 | $0.04 | 112.9x | +16% |
| FY2012 Q4 | Mon Dec 31 2012 00:00:00 GM | $7.60 | $0.15 | 50.7x | -48% |
| FY2011 Q2 | $10.18 | $1.32 | 7.7x | -92% | |
| FY2010 Q4 | Fri Dec 31 2010 00:00:00 GM | $9.25 | $3.17 | 2.9x | -97% |
| FY2010 Q2 | Wed Jun 30 2010 00:00:00 GM | $10.06 | $4.94 | 2.0x | -98% |
Average P/E for displayed period: 97.5x
See DXR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DXR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DXR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDXR — Frequently Asked Questions
Quick answers to the most common questions about buying DXR stock.
Is DXR stock overvalued or undervalued?
DXR trades at 87.8x P/E, above its 5-year average of 25.2x. The 90th percentile ranking indicates a premium to historical valuation.
How does DXR's valuation compare to peers?
Daxor Corporation P/E of 87.8x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is DXR's PEG ratio?
DXR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1989-2025.